Isolinderalactone

CAS No. 957-66-4

Isolinderalactone( —— )

Catalog No. M25015 CAS No. 957-66-4

Isolinderalactone shows anti-inflammatory and anticancer capacity, and it exhibits moderate iNOS inhibitory activity, with the IC50 value of 0.30 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 143 In Stock
5MG 155 In Stock
10MG 258 In Stock
25MG 436 In Stock
50MG 612 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Isolinderalactone
  • Note
    Research use only, not for human use.
  • Brief Description
    Isolinderalactone shows anti-inflammatory and anticancer capacity, and it exhibits moderate iNOS inhibitory activity, with the IC50 value of 0.30 uM.
  • Description
    Isolinderalactone shows anti-inflammatory and anticancer capacity, and it exhibits moderate iNOS inhibitory activity, with the IC50 value of 0.30 uM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    NOS
  • Recptor
    STAT3|iNOS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    957-66-4
  • Formula Weight
    244.29
  • Molecular Formula
    C15H16O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CC1=COC2=C1[C@H]3[C@H](C(=C)C(=O)O3)[C@@](C2)(C)C=C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wong S L , Chang H S , Wang G J , et al. Secondary metabolites from the roots of Neolitsea daibuensis and their anti-inflammatory activity.[J]. Journal of Natural Products, 2011, 74(12):2489-96.
molnova catalog
related products
  • Rutaevin

    Rutaevin shows the inhibitory activity on nitric oxide (NO) production in lipopolysaccharide-activated RAW264.7 macrophages, it may be as a valuable anti-inflammatory agent.

  • Euscaphic acid

    Euscaphic acid has anti-diabetic, and anti-inflammatory activities, it inhibits LPS-induced inflammatory responses by interference with the clustering of TRAF6 with IRAK1 and TAK1, resulting in blocking the activation of IKK and MAPKs signal transduction to downregulate NF-κB activations.

  • Cindunistat

    Cindunistat (free base) is an orally available selective iNOS inhibitor for the study of arthritis.